XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   73,317      
Beginning balance at Dec. 31, 2023 $ 538,085 $ 73 $ 942,280 $ 582 $ (404,850)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of new capped calls associated with the 2029 convertible senior notes (93,438)   (93,438)    
Partial termination of existing capped calls associated with the 2025 convertible senior notes 539   539    
Issuance of common stock upon exercise of stock options (in shares)   21      
Issuance of common stock upon exercise of stock options 423   423    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,661      
Issuance of common stock upon vesting of restricted stock units 2 $ 2      
Issuance of common stock under ESPP (in shares)   209      
Issuance of common stock under ESPP 9,522   9,522    
Stock-based compensation 133,579   133,579    
Other comprehensive income 1,246     1,246  
Net income (loss) (24,372)       (24,372)
Ending balance (in shares) at Sep. 30, 2024   75,208      
Ending balance at Sep. 30, 2024 565,586 $ 75 992,905 1,828 (429,222)
Beginning balance (in shares) at Jun. 30, 2024   74,719      
Beginning balance at Jun. 30, 2024 525,878 $ 75 951,048 (502) (424,743)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   6      
Issuance of common stock upon exercise of stock options 26   26    
Issuance of common stock upon vesting of restricted stock units (in shares)   483      
Issuance of common stock upon vesting of restricted stock units   $ 0      
Stock-based compensation 41,831   41,831    
Other comprehensive income 2,330     2,330  
Net income (loss) (4,479)       (4,479)
Ending balance (in shares) at Sep. 30, 2024   75,208      
Ending balance at Sep. 30, 2024 565,586 $ 75 992,905 1,828 (429,222)
Beginning balance (in shares) at Dec. 31, 2024   75,808      
Beginning balance at Dec. 31, 2024 622,192 $ 76 1,039,125 636 (417,645)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   155      
Issuance of common stock upon exercise of stock options 3,118   3,118    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,914      
Issuance of common stock upon vesting of restricted stock units   $ 2 (2)    
Issuance of common stock under ESPP (in shares)   337      
Issuance of common stock under ESPP 7,921   7,921    
Stock-based compensation 122,239   122,239    
Other comprehensive income 113     113  
Net income (loss) 19,703       19,703
Ending balance (in shares) at Sep. 30, 2025   78,214      
Ending balance at Sep. 30, 2025 775,286 $ 78 1,172,401 749 (397,942)
Beginning balance (in shares) at Jun. 30, 2025   77,263      
Beginning balance at Jun. 30, 2025 717,377 $ 77 1,133,107 108 (415,915)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   150      
Issuance of common stock upon exercise of stock options 3,087   3,087    
Issuance of common stock upon vesting of restricted stock units (in shares)   801      
Issuance of common stock upon vesting of restricted stock units   $ 1 (1)    
Stock-based compensation 36,208   36,208    
Other comprehensive income 641     641  
Net income (loss) 17,973       17,973
Ending balance (in shares) at Sep. 30, 2025   78,214      
Ending balance at Sep. 30, 2025 $ 775,286 $ 78 $ 1,172,401 $ 749 $ (397,942)